Status:
ACTIVE_NOT_RECRUITING
Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning Pathway
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Alberta Health services
Conditions:
Acute Respiratory Distress Syndrome
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment of patients with Hypoxemic respiratory failure (HRF) and Acute Respiratory Distress Syndrome (ARDS) is complex. Therapies that have been shown to save the lives of patients with HRF and ARDS...
Detailed Description
Hypoxemic respiratory failure (HRF) and ARDS are common conditions among patients admitted to the Intensive care unit (ICU). Treatment of these patients is complex. Evidence based therapies that can i...
Eligibility Criteria
Inclusion
- Admitted to the one of the 17 adult Intensive Care Units in Alberta
- Invasively mechanically ventilated
Exclusion
- none
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
19916 Patients enrolled
Trial Details
Trial ID
NCT04744298
Start Date
April 1 2021
End Date
October 1 2025
Last Update
June 25 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Peter Lougheed Centre (PLC)
Calgary, Alberta, Canada, T1Y 6J4
2
Foothills Hospital Intensive Care Unit
Calgary, Alberta, Canada, T2N 2T9
3
Foothills Medical Center Cardiovascular ICU
Calgary, Alberta, Canada, T2N 2T9
4
Rockyview General Hospital
Calgary, Alberta, Canada, T2V 1P9